# Xesgalicia

> Xesgalicia is a VC fund in Santiago De Compostela backing Software and Biotechnology. See 34 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Santiago De Compostela, Spain
- Total investments: 34
- Last investment: Apr 2026
- Lead investor: 15%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/xesgalicia
- Website: http://www.xesgalicia.gal

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $304k–$5.9M |
| Venture - Series Unknown | $904k–$5.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 8 | 24% |
| Biotechnology | 5 | 15% |
| B2B | 3 | 9% |
| Pharmaceutical | 3 | 9% |
| Information Technology | 3 | 9% |

53 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 15 | 44% |
| Venture - Series Unknown | 5 | 15% |
| Funding Round | 4 | 12% |
| Pre-Seed | 2 | 6% |
| Series A | 1 | 3% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 24 | 71% |
| Portugal | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Iteria Biopharma | Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs. | $5.9M | Seed | Apr 16, 2026 |  |
| VigSec-Drone | VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness. | $1.2M | Venture - Series Unknown | Dec 11, 2025 |  |
| Kreios Space | Kreios Space is a deep-tech startup based on the R&D of technologies for enabling the Very Low Earth Orbit (VLEO). The company was founded on May 2021 by 6 founders and is currently aimed at prototyping and getting into the market an Air-breathing electric propulsion system, which will allow the satellites to operate in orbits much closer tothe Earth (from 100 to 400Km height meanwhile they are currently set over 500Km), providing a huge improvement to the resolution for both telecommunications and Earth observation. | $9.5M | Seed | Sep 17, 2025 |  |
| Neboda | Neboda is a science and technology that aims to transform agriculture into a more sustainable, competitive, and appealing business while also producing a better and healthier product. | $2.2M | Seed | Jul 21, 2025 |  |
| Kreios Space | Kreios Space is a deep-tech startup based on the R&D of technologies for enabling the Very Low Earth Orbit (VLEO). The company was founded on May 2021 by 6 founders and is currently aimed at prototyping and getting into the market an Air-breathing electric propulsion system, which will allow the satellites to operate in orbits much closer tothe Earth (from 100 to 400Km height meanwhile they are currently set over 500Km), providing a huge improvement to the resolution for both telecommunications and Earth observation. | $2.5M | Pre-Seed | Jul 24, 2024 |  |
| Appentra | In the software world, new technologies have recently put on the hands of companies and developers highly powerful tools which involve a leap in computing capabilities. First, heterogeneous multicore systems have become small and affordable supercomputers. Second, Artificial Intelligence, Machine Learning, Deep Learning, and big data arerevolutionizing entire economic sectors. These powerful tools were up until now only accessible to a minority of organizations with massive resources but finally they have become mainstream. However, to take advantage of these powerful capabilities, companies need to adopt the computing technologies created for years in (HPC) market, particularly parallel computing. PARALLELWARE ANALYZER is the most complete and fast software aimed to enable developers to overcome the complexity of parallel programming. Appentra is a Deep Tech global company that delivers products based on the Parallelware technology, a unique approach to static code analysis specialized in concurrency and parallelism. Our aim is to make parallel programming easier, enabling everyone to make the best use of parallel computing hardware from the multi-cores in a laptop to the fastest supercomputers. | $5.5M | Seed | Sep 19, 2023 |  |
| Envita | Envita is a social innovation start-up for the development of innovative digital solutions for organizations. | $547.6K | Seed | Apr 19, 2023 |  |
| BioFlyTech | Bioflytech is an animal feed firm that specializes in the commercial manufacture of insect protein. Incorporating insect protein into current value chains, such as companion animal, aquaculture, or poultry, increases the circularity and sustainability of existing food chains. As a result, more proteins are produced while minimizing environmentaleffect and lowering water consumption and antibiotic use in the food production chain. | $5.5M | Venture - Series Unknown | Mar 08, 2023 |  |
| Aerocámaras | Company dedicated to training and professional services with drones and UAV. We develop our activity in 14 countries. We have hybrid drones for TV, Cinema, Advertising, Emergencies, Security, Inspections, Agriculture, Fishing, Inspections, Audio-visuals, Industrial, among others services. 20 drone pilot training centers in Spain; 2 approvedemergency and safety pilot training centers. We develop customized drones for all types of applications such as the hybrid drone, unique in the world, with more than four hours of flight autonomy. Sale of first brands of drones as DJI, YUNEEC, etc. | $904.1K | Venture - Series Unknown | Dec 27, 2022 |  |
| Oncostellae | Oncostellae has been founded in 2013 by a group of researchers (chemists, biochemists and pharmacologists) who have a common track record in developing clinical drug candidates until phase II. Our objective is to discover and develop small molecule drugs for the treatment of cancer by generating pharmaceutical research programs around novelmodulators of validated cancer targets like e.g. nuclear receptors and kinases. The company’s strategy includes running the discovery and development process with limited headcounts and focusing internal activities on project management, medicinal chemistry and in vitro pharmacology. The remaining activities of the R&D process like in vivo pharmacology, toxicology and clinical trials are subcontracted to qualified providers.The commercial goal is to license a clinical drug candidate including intellectual property and preclinical/clinical data package to a consolidated pharmaceutical or biotechnological company. | $3.2M | Venture - Series Unknown | Nov 03, 2022 |  |

10 of 34 investments shown.

## Co-investors
- [Vigo Activo](https://shizune.co/investors/profile/vigo-activo-6ebd) — VC Fund, 10 deals together
- [Unirisco Galicia](https://shizune.co/investors/profile/unirisco) — VC Fund, 9 deals together
- [Criteria Venture Tech](https://shizune.co/investors/profile/caixa-capital) — VC Fund, 7 deals together
- [Armilar Venture Partners](https://shizune.co/investors/profile/espirito-santo-ventures) — VC Fund, 3 deals together
- [K Fund](https://shizune.co/investors/profile/kfund) — VC Fund, 3 deals together
- [Bankinter](https://shizune.co/investors/profile/bankinter) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [All Investors in Spain](https://shizune.co/investors/investors-spain)
- [All VC Funds in Spain](https://shizune.co/investors/vc-funds-spain)
- [SaaS Investors in Spain](https://shizune.co/investors/saas-investors-spain)
- [SaaS VC Funds in Spain](https://shizune.co/investors/saas-vc-funds-spain)
- [Software VC Funds in Spain](https://shizune.co/investors/software-vc-funds-spain)
- [Enterprise VC Funds in Spain](https://shizune.co/investors/enterprise-vc-funds-spain)

## FAQ

### What does Xesgalicia invest in?

Xesgalicia invests primarily in Software, Biotechnology and B2B startups, most often at Seed and Venture - Series Unknown stage. Most of the 34 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Xesgalicia's check size?

Xesgalicia typically joins rounds of $304k–$5.9M at Seed and $904k–$5.5M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Xesgalicia participates in.

### When did Xesgalicia last invest?

The most recent investment recorded for Xesgalicia closed in Apr 2026. Shizune tracks 34 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co